关掉卵巢之后,子宫内膜还走不走自己的钟

Written by

in

Language

Evidence level: B

内膜有没有自己的节拍,取决于一个可区分的检验:把激素这个上游驱动关掉之后,它是停摆,还是开始自由运行。

正文

上一篇《在人血里找 29.5 天的钟》讨论的是”读数口”——外周血。但外周血只是一面镜子,真正该有月级节律的靶组织是子宫内膜。这一篇问一个更硬的问题:内膜那个 28 天左右的节律,是激素写上去的,还是它自己本来就会走?

一个可拆的实验

海洋环节虫给了模板:它的昼夜钟和近月钟能拆开,打掉昼夜钟,近月钟照样走(PMID 24075994)。所以”独立近月钟”在无脊椎动物身上已是既成事实。哺乳动物这边的问题是——内膜节律里,多少属于内膜自己的钟,多少只是卵巢激素斜坡的被动读数。

用 GnRH 激动剂做垂体降调节,把卵巢压下去,造一个”没有周期性激素驱动”的窗口,看内膜还报不报时。两个假说给出不同的预测:

  • 激素驱动假说:内膜节律是激素的被动读出 → 激素撤除,节律消失,输出是一条平线。
  • 内源钟假说:激素只是对时信号 → 钟不会停,它脱离驱动源自由运行(free-running),周期可能漂到新值。

关键是分清两种结果:节律消失(激素驱动)还是节律换周期(内源钟自由运行)。只报”降调节后看不到 28 天成分”毫无意义,两种假说都会得到这个结果;必须报的是有没有自由运行周期、以及它是多少。这与环节虫实验同构:真正的解耦标志不是”一个没了”,而是”另一个换了节奏还在走”(PMID 38764210 展示的正是这种可拆结构)。

但”关掉卵巢”这只手不干净

GnRH 降调节不是单纯的”断供”。子宫内膜、肌层、肌瘤上都表达 GnRH 受体(PMID 21528253、PMID 26715597)。更关键的是,GnRH 类似物对内膜细胞有直接作用:体外直接诱导内膜细胞凋亡、抑制增殖(PMID 12923126、PMID 14505742),腺癌细胞系上同样如此(PMID 24591918);拮抗剂削弱内膜基质细胞的生长能力(PMID 35120552);降调节还改变内膜的类固醇受体表达谱(PMID 19640894)。

于是”降调节之后内膜的钟变了”有了两个互斥解释:没了激素,或 GnRH 直接改了内膜细胞状态。 要分开得靠额外设计——拮抗剂与激动剂对照,把”撤激素”与”GnRH 暴露”拆成两臂。严格说,GnRH 降调节给出的不是实验,是混淆的合成剂量。

取样这一关也不好过

内膜不能天天抽。要覆盖 28 天周期,唯一办法是反复活检——而活检本身就是干预:损伤、炎症、修复都会扰动组织状态,等于一边测量一边改样本。
现有两套大规模内膜图谱(PMID 32929266、PMID 34857954)都是横断面的:不同的人、不同周期阶段拼出一条时间轴。这条轴上的周期性,多少是个人的钟在走,多少只是不同人的状态斜坡,分不开。

替代方案是内膜类器官——可长期培养并响应激素(PMID 28394884)、可自更新(PMID 31666317)、可做上皮-基质共培养(PMID 37572651)、有蜕膜化衰老模型(PMID 34487490)。好处是能在无激素培养基里跑纵向序列;代价是脱离体内(无血供、无免疫)。两条路各缺一半:体内能纵向但不能无激素,体外能无激素但不算真在体内。

动物侧的线索是不对称的

“激素 → 钟”这个方向证据不少:雌激素直接调制子宫 PER2 节律(PMID 18728223);基质细胞里是孕酮(而非雌激素)同步化钟振荡(PMID 19096762);大鼠蜕膜化中 Per2 下调(PMID 21182399),孕鼠内膜基质细胞的钟基因谱已被刻画(PMID 23847593);REV-ERBα 受激素调控并抑制下游基因(PMID 25007867、PMID 26811051)。

反过来,钟对激素的独立性几乎没有直接证据。子宫 Bmal1 敲除会造成胎盘血管化受损与宫内胎儿死亡(PMID 35886985),说明钟对生殖功能必需;但这是受孕之后的表型,不能外推到”未孕内膜是否保留独立节律”。雌性哺乳动物 SCN 与核受体的双向调控框架已被提出(PMID 40225034)——框架有了,实验没做。

临床现实把这个窗口填掉了

还有一刀更现实:临床上 GnRH 降调节之后,通常立即叠加上外源雌孕激素准备内膜(PMID 30501453、PMID 36604214、PMID 37902321)。也就是说,你想研究的那个”无激素内膜”状态,恰好是临床路径里被马上补上的那个状态。 真正接近它的窗口很窄——绝经后、卵巢功能衰竭,或降调节后的短暂空档。这也解释了这块空白为何一直没被填:临床上没理由制造那个状态。

旁证都在别的方向:控促排卵会打乱内膜钟节律(PMID 39020493),持续人工光照会扰动中枢与外周生殖钟并改变子宫生理(PMID 35399124)——内膜钟确实可被外部干预改写,只是没人在”撤激素”方向单独测过。

落到易学上

《素问·上古天真论》讲女子:”二七而天癸至,任脉通,太冲脉盛,月事以时下,故有子。”这句话里其实有两个东西:”天癸至”与”太冲脉盛”——前者是上游的系统性驱动,后者是局部的本钱。古人并列写成两句,不是同义反复。现代这套实验要做的,正是把它们拆成两个自变量:把”天癸”抽掉,看”太冲脉”还能不能自己盛。

再往上一层:《易·复》说”反复其道,七日来复,天行也”,把”复”归给”天行”,也就是自发;《道德经》说得更直白——”独立而不改,周行而不殆”。这八个字正是内源振荡器的定义:不靠外物推动,也能周而复始。 区别只在于:古人说这话是表彰,我们说这话是判据——判据要拿数据兑现,兑不出,就退回成漂亮话。

证据与局限

已验证: 环节虫昼夜钟与近月钟可被独立解耦(PMID 24075994),近月计时可由昼夜周期的计数决定(PMID 38764210);激素是内膜钟的有效驱动/同步信号——雌激素直接调制子宫 PER2 节律(PMID 18728223)、孕酮而非雌激素同步化内膜基质细胞钟振荡(PMID 19096762)、蜕膜化伴随 Per2 下调(PMID 21182399)与钟基因谱改变(PMID 23847593)、REV-ERBα 受激素调控并抑制下游基因(PMID 25007867、PMID 26811051);子宫钟对生殖功能必需(Bmal1 敲除致胎盘血管化受损与胎儿死亡,PMID 35886985);人子宫内膜表达 GnRH 受体(PMID 21528253、PMID 26715597),GnRH 类似物对内膜细胞有直接促凋亡/抗增殖作用(PMID 12923126、PMID 14505742、PMID 24591918、PMID 35120552)并改变类固醇受体谱(PMID 19640894);人内膜单细胞与时空图谱已完成但为横断面设计(PMID 32929266、PMID 34857954);人内膜类器官可长期培养、响应激素并支持共培养(PMID 28394884、PMID 31666317、PMID 37572651、PMID 34487490);GnRH 降调节后临床常规叠加外源激素准备内膜(PMID 30501453、PMID 36604214、PMID 37902321);内膜钟可被外部干预改写(PMID 39020493、PMID 35399124)。

部分验证: 雌性哺乳动物中枢钟与核受体对节律的双向调控框架已被提出(PMID 40225034),但尚无针对”激素撤除后未孕内膜钟是否保留”的纵向实验;体外与动物模型提示激素是驱动/同步源,但独立振荡的充分性未被检验。

待验证: ①GnRH 降调节造成的”无周期性激素”窗口内,人子宫内膜是否保留独立于激素驱动的周期成分(尚无研究执行);②若保留,其自由运行周期是否为 28 天、29.5 天或其他值(这是区分两假说的关键读数);③GnRH 类似物对内膜细胞的直接作用与激素撤除效应能否在同一实验中定量分离;④反复活检本身对内膜钟的扰动幅度是否小于待测效应量(决定体内纵向设计是否可行);⑤类器官在无激素培养基中的自由运行周期与体内是否一致(决定体外替代能否外推)。

相关阅读

证据等级: B
参考文献: PMID 24075994, PMID 38764210, PMID 21528253, PMID 26715597, PMID 12923126, PMID 14505742, PMID 24591918, PMID 35120552, PMID 19640894, PMID 32929266, PMID 34857954, PMID 28394884, PMID 31666317, PMID 37572651, PMID 34487490, PMID 18728223, PMID 19096762, PMID 21182399, PMID 23847593, PMID 25007867, PMID 26811051, PMID 35886985, PMID 40225034, PMID 30501453, PMID 36604214, PMID 37902321, PMID 39020493, PMID 35399124


免责说明:本文属传统知识与科学文献的整理、对照与研究设计讨论,仅供理解与参考,不构成医疗建议,不能替代专业诊断与治疗。文中涉及的效应量、频率区间与暴露结论多为研究报告层面的推断,个体情况差异很大;如有身体不适或健康疑虑,请就医并由专业医师判断。

Does the Endometrium Still Follow Its Own Clock After Ovarian Removal?

Evidence level: B

Whether the endometrium possesses its own rhythm depends on a distinguishable test: does it stall when the upstream hormonal drive is cut off, or does it begin to run freely?

Main Text

The previous article, “Finding a 29.5-Day Clock in Peripheral Blood,” discussed the “reading window”—peripheral blood. However, peripheral blood is merely a mirror; the true target tissue exhibiting monthly rhythms is the endometrium. This article addresses a harder question: Is the ~28-day rhythm of the endometrium written by hormones, or does it run independently?

A Dissectable Experiment

Marine annelids provided a template: their circadian and near-monthly clocks can be uncoupled; knocking out the circadian clock leaves the near-monthly clock running (PMID 24075994). Thus, an “independent near-monthly clock” is an established fact in invertebrates. The question for mammals is whether the endometrial rhythm consists of a portion intrinsic to the tissue and a portion merely a passive readout of ovarian hormone gradients.

Using GnRH agonists to induce pituitary downregulation suppresses the ovaries, creating a window with “no periodic hormonal drive” to observe if the endometrium still signals time. Two hypotheses offer different predictions:

  • Hormone Drive Hypothesis: The endometrial rhythm is a passive readout of hormones → Hormone withdrawal causes rhythm cessation, resulting in a flat output line.
  • Endogenous Clock Hypothesis: Hormones serve only as zeitgebers (time-setting signals) → The clock does not stop; it free-runs independent of the drive source, potentially drifting to a new period.

The critical distinction lies between rhythm disappearance (hormone drive) and rhythm period shift (endogenous clock free-running). Reporting merely “no 28-day component observed after downregulation” is meaningless, as both hypotheses yield this result; one must report whether a free-running period exists and what its value is. This mirrors the annelid experiment: the true marker of uncoupling is not “one lost,” but “the other continues with a changed rhythm” (PMID 38764210 demonstrates this decoupled structure).

But the “Shutting Off Ovaries” Hand Is Not Clean

GnRH downregulation is not a simple “supply cut.” The endometrium, myometrium, and fibroids all express GnRH receptors (PMID 21528253, PMID 26715597). Crucially, GnRH analogs exert a direct effect on endometrial cells: they induce apoptosis and inhibit proliferation in vitro (PMID 12923126, PMID 14505742), similarly in adenocarcinoma cell lines (PMID 24591918); antagonists weaken the growth capacity of endometrial stromal cells (PMID 35120552); downregulation alters the endometrial steroid receptor expression profile (PMID 19640894).

Thus, “the endometrial clock changes after downregulation” has two mutually exclusive explanations: hormone removal or GnRH directly altering endometrial cell states. Separation requires additional design—comparing antagonists with agonists to split “hormone withdrawal” from “GnRH exposure.” Strictly speaking, GnRH downregulation provides not an experiment but a confounded synthetic dose.

Sampling Is Also Difficult

Endometrium cannot be sampled daily. To cover a 28-day cycle, repeated biopsy is the only option—but biopsy itself is an intervention: damage, inflammation, and repair all perturb tissue states, effectively measuring while modifying the sample.

Existing large-scale endometrial atlases (PMID 32929266, PMID 34857954) are cross-sectional: different individuals and cycle stages are stitched into a timeline. The periodicity on this axis reflects partly an individual’s clock running and partly just different states across individuals, which cannot be distinguished.

An alternative is endometrial organoids—cultivable long-term and responsive to hormones (PMID 28394884), capable of self-renewal (PMID 31666317), supporting epithelial-stromal co-culture (PMID 37572651), and possessing decidualization aging models (PMID 34487490). The advantage is running longitudinal sequences in hormone-free media; the cost is loss of in vivo context (no blood supply, no immune system). Each path lacks half: in vivo allows longitudinal but not hormone-free; in vitro allows hormone-free but is not truly in vivo.

Clues from the Animal Side Are Asymmetric

Evidence for “Hormone → Clock” is abundant: estrogen directly modulates uterine PER2 rhythms (PMID 18728223); progesterone (not estrogen) synchronizes clock oscillations in stromal cells (PMID 19096762); Per2 is downregulated during rat decidualization (PMID 21182399), and the clock gene profile of pregnant mouse endometrial stromal cells has been characterized (PMID 23847593); REV-ERBα is hormone-regulated and suppresses downstream genes (PMID 25007867, PMID 26811051).

Conversely, there is almost no direct evidence for clock independence from hormones. Knockout of uterine Bmal1 causes impaired placental vascularization and intrauterine fetal death (PMID 35886985), indicating the clock is essential for reproductive function; however, this is a post-conception phenotype and cannot be extrapolated to “whether non-pregnant endometrium retains independent rhythms.” A bidirectional regulatory framework between the SCN and nuclear receptors in female mammals has been proposed (PMID 40225034)—the framework exists, but the experiment has not been performed.

Clinical Reality Fills This Window

There is a more practical knife: clinically, after GnRH downregulation, exogenous estrogen and progesterone are typically immediately overlaid to prepare the endometrium (PMID 30501453, PMID 36604214, PMID 37902321). In other words, the very “hormone-free endometrium” state you wish to study is immediately replenished in the clinical pathway. The window truly approaching this state is narrow—postmenopause, ovarian failure, or the brief gap after downregulation. This explains why this blank has never been filled: there is no clinical reason to create that state.

Corroborating evidence lies elsewhere: controlling ovulation disrupts endometrial clock rhythms (PMID 39020493), and continuous artificial light perturbs central and peripheral reproductive clocks, altering uterine physiology (PMID 35399124)—the endometrial clock can indeed be rewritten by external intervention, but no one has measured it specifically in the “withdrawal of hormone” direction alone.

Falling Back to Yijing Studies

The Su Wen · Shang Gu Zhen Lun states regarding women: “At seventeen years and two months, Tian Gui arrives; the Ren Meridian becomes open, the Tai Chong Meridian becomes abundant; menstruation occurs monthly, hence conception is possible.” Within this statement lie two distinct elements: “Tian Gui arrives” and “Tai Chong Meridian becomes abundant”—the former is the upstream systemic drive, the latter the local foundation. The ancients wrote them as two sentences, not as tautology. Modern experiments aim precisely to split these into two independent variables: remove “Tian Gui” and observe if “Tai Chong Meridian” can still become abundant on its own.

Going further up: The I Ching · Fu states “Repeating the way, returning every seven days; this is the movement of Heaven,” attributing “Fu” (return) to “Tian Xing” (Heavenly movement), i.e., spontaneous; the Dao De Jing states it even more plainly—”Independent without changing, circulating without ceasing.” These eight characters define the endogenous oscillator: capable of cyclical motion without relying on external push. The difference lies only in tone: the ancients spoke this as praise; we speak it as a criterion—a criterion must be validated by data; if not validated, it retreats to pretty talk.

Evidence and Limitations

Verified: The annelid circadian and near-monthly clocks can be independently uncoupled (PMID 24075994); near-monthly timing can be determined by counting circadian cycles (PMID 38764210); hormones are effective drivers/synchronizers for the endometrial clock—estrogen directly modulates uterine PER2 rhythms (PMID 18728223), progesterone synchronizes endometrial stromal cell clock oscillations rather than estrogen (PMID 19096762), decidualization accompanies Per2 downregulation (PMID 21182399) and clock gene profile changes (PMID 23847593), REV-ERBα is hormone-regulated and suppresses downstream genes (PMID 25007867, PMID 26811051); uterine clock is essential for reproductive function (Bmal1 knockout causes impaired placental vascularization and fetal death, PMID 35886985); human endometrium expresses GnRH receptors (PMID 21528253, PMID 26715597), GnRH analogs exert direct pro-apoptotic/anti-proliferative effects on endometrial cells (PMID 12923126, PMID 14505742, PMID 24591918, PMID 35120552) and alter steroid receptor profiles (PMID 19640894); human endometrial single-cell and spatiotemporal atlases are complete but designed cross-sectionally (PMID 32929266, PMID 34857954); human endometrial organoids can be cultured long-term, respond to hormones, and support co-culture (PMID 28394884, PMID 31666317, PMID 37572651, PMID 34487490); GnRH downregulation clinically routinely involves overlaying exogenous hormones to prepare the endometrium (PMID 30501453, PMID 36604214, PMID 37902321); endometrial clocks can be rewritten by external intervention (PMID 39020493, PMID 35399124).

Partially Verified: A bidirectional regulatory framework between central clocks and nuclear receptors for rhythms in female mammals has been proposed (PMID 40225034), but no longitudinal experiments exist regarding “whether the endometrial clock in non-pregnant tissue is retained after hormone withdrawal”; in vitro and animal models suggest hormones are drivers/synchronizers, but the sufficiency of independent oscillation remains untested.

To Be Verified: ① Whether human endometrium retains a cycle component independent of hormonal drive within the “no periodic hormone” window created by GnRH downregulation (no study has executed this); ② If retained, whether the free-running period is 28 days, 29.5 days, or another value (this is the key reading distinguishing the two hypotheses); ③ Whether direct effects of GnRH analogs on endometrial cells and hormone withdrawal effects can be quantitatively separated in the same experiment; ④ Whether the perturbation magnitude caused by repeated biopsy itself is smaller than the effect size to be measured (determining feasibility of in vivo longitudinal design); ⑤ Whether free-running periods in organoids under hormone-free media match those in vivo (determining if in vitro alternatives can be extrapolated).

Related Reading

Evidence Level: B
References: PMID 24075994, PMID 38764210, PMID 21528253, PMID 26715597, PMID 12923126, PMID 14505742, PMID 24591918, PMID 35120552, PMID 19640894, PMID 32929266, PMID 34857954, PMID 28394884, PMID 31666317, PMID 37572651, PMID 34487490, PMID 18728223, PMID 19096762, PMID 21182399, PMID 23847593, PMID 25007867, PMID 26811051, PMID 35886985, PMID 40225034, PMID 30501453, PMID 36604214, PMID 37902321, PMID 39020493, PMID 35399124


Disclaimer: This article compiles traditional knowledge and scientific literature for comparison and research-design discussion only. It is not medical advice and cannot replace professional diagnosis or treatment. Effect sizes, frequency ranges and exposure conclusions cited here are largely inferences at the research-report level, and individual circumstances vary widely. If you have any discomfort or health concerns, please consult a physician.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *